Core Insights - Biotalys is undergoing a strategic refocus to concentrate resources on its highest-priority programs and streamline operations [1][2] - The company aims to reduce total cash burn by €20 million until the end of 2028 compared to its current operating structure [2] - The focus will be on advancing its lead biofungicide assets, particularly EVOCA NG and BioFun-6, while maintaining partnerships for other programs [3] Organizational Changes - Biotalys plans to right-size its organizational structure and suspend early-stage activities to lower operating expenses [2] - The workforce will be reduced by 30 employees to align with the new strategy [4] - The company confirms its cash runway extends into May 2026 and is exploring financing options to support its refocused portfolio [4][9] Product Development - EVOCA NG is expected to be Biotalys' first commercial biofungicide, with a planned launch in the USA in 2029 and in Europe in 2030, targeting a market worth over USD 1.1 billion [5] - The U.S. EPA has approved the first-generation version of EVOCA, facilitating a shorter regulatory review process for EVOCA NG [6] Company Background - Biotalys is an AgTech company focused on developing protein-based biocontrol solutions for sustainable crop protection [7] - The company was founded in 2013 as a spin-off from the VIB and is based in Ghent, Belgium [7] - Biotalys employs an average of 59 employees as of 2025 [11]

Core Insights - Biotalys is progressing with the regulatory approval of its first protein-based biocontrol product, EVOCA, with the U.S. EPA confirming that the scientific review is ongoing and all additional information requests have been addressed [2][3] - The company now anticipates that the final steps of the registration procedure will occur in Q4 2025, a delay from the previous expectation of completion by the end of September [2] - EVOCA is designed to control fungal diseases such as Botrytis and powdery mildew, providing biodegradable solutions for fruit and vegetable growers [3] Company Overview - Biotalys is an AgTech company focused on developing precision biocontrol solutions based on proteins for crop protection in pre- and post-harvest markets [5] - The company utilizes its AGROBODY technology platform to create products that combine the efficacy of traditional chemical solutions with the environmental benefits of biological alternatives [5] - Founded in 2013 as a spin-off from the VIB, Biotalys is headquartered in Ghent, Belgium, and is listed on Euronext Brussels [5]